These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 3147421
1. Evidence for the role of active oxygen in guanidine synthesis in haemodialysis patients and in vitro. Nagase S, Aoyagi K, Sakamoto M, Narita M, Tojo S. Nephrol Dial Transplant; 1988; 3(6):790-4. PubMed ID: 3147421 [Abstract] [Full Text] [Related]
2. Guanidino compounds in uraemic dialysed patients. De Deyn P, Marescau B, Lornoy W, Becaus I, Lowenthal A. Clin Chim Acta; 1986 Jun 15; 157(2):143-50. PubMed ID: 3719996 [Abstract] [Full Text] [Related]
3. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations. De Deyn PP, Robitaille P, Vanasse M, Qureshi IA, Marescau B. Nephron; 1995 Jun 15; 69(4):411-7. PubMed ID: 7777105 [Abstract] [Full Text] [Related]
4. Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture. De Deyn PP, Macdonald RL. Ann Neurol; 1990 Nov 15; 28(5):627-33. PubMed ID: 2135950 [Abstract] [Full Text] [Related]
6. [Chronic renal failure and guanidino compounds]. Kinoshita T. Yakugaku Zasshi; 1997 Nov 15; 117(10-11):673-80. PubMed ID: 9414581 [Abstract] [Full Text] [Related]
7. Plasma, urinary, and erythrocyte concentrations of guanidino compounds in patients with chronic renal failure. Tanaka A, Takahashi Y, Mizokuchi M, Shimada N, Koide H. Ren Fail; 1999 Sep 15; 21(5):499-514. PubMed ID: 10516995 [Abstract] [Full Text] [Related]
8. Serum guanidino compound levels and clearances in uremic patients treated with continuous ambulatory peritoneal dialysis. De Deyn PP, Marescau B, Swartz RD, Hogaerth R, Possemiers I, Lowenthal A. Nephron; 1990 Sep 15; 54(4):307-12. PubMed ID: 2325795 [Abstract] [Full Text] [Related]
9. [Studies on guanidine compounds in uremia: reevaluation of serum GSA in relation to acute symptoms of uremia (author's transl)]. Tofuku Y, Kuroda M, Kita T, Takeda R. Nihon Jinzo Gakkai Shi; 1980 Mar 15; 22(3):249-58. PubMed ID: 7382166 [No Abstract] [Full Text] [Related]
10. Plasma concentration and urinary excretion of guanidine derivatives in normal subjects and patients with renal failure. Sawynok J, Dawborn JK. Clin Exp Pharmacol Physiol; 1975 Mar 15; 2(1):1-15. PubMed ID: 1126056 [Abstract] [Full Text] [Related]
12. Kinetic behavior of urea is different from that of other water-soluble compounds: the case of the guanidino compounds. Eloot S, Torremans A, De Smet R, Marescau B, De Wachter D, De Deyn PP, Lameire N, Verdonck P, Vanholder R. Kidney Int; 2005 Apr 15; 67(4):1566-75. PubMed ID: 15780113 [Abstract] [Full Text] [Related]
13. Effect of hemodialysis on serum guanidine and methylguanidine levels. Perez G, Santos B. Proc Clin Dial Transplant Forum; 1973 Apr 15; 3():110-3. PubMed ID: 4806625 [No Abstract] [Full Text] [Related]
14. Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency. Marescau B, Nagels G, Possemiers I, De Broe ME, Becaus I, Billiouw JM, Lornoy W, De Deyn PP. Metabolism; 1997 Sep 15; 46(9):1024-31. PubMed ID: 9284891 [Abstract] [Full Text] [Related]
20. Serum guanidino compound levels and the influence of a single hemodialysis in uremic patients undergoing maintenance hemodialysis. De Deyn P, Marescau B, Lornoy W, Becaus I, Van Leuven I, Van Gorp L, Lowenthal A. Nephron; 1987 Sep 15; 45(4):291-5. PubMed ID: 3587469 [Abstract] [Full Text] [Related] Page: [Next] [New Search]